Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop SystemsEversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and high performance
Are AI Crypto Trading Bots Suitable for Crypto Beginners? BulkQuant Launches an Automated Crypto Trading AppBulkQuant introduces an automated crypto trading app designed to help beginners access AI crypto trading bots with a simpler workflow, reduced manual operation, and clearer automation features.
SKG Launches PS700 Neck Massager, Bringing Deep Kneading, Layered Heat, and Immersive Audio to Everyday RecoveryThe new wearable recovery device pairs deep-kneading massage, layered warmth, and immersive audio to help ease neck tension
All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network IntegrationNEW YORK, June 06, 2026 (GLOBE NEWSWIRE) -- All In FutureTech Alliance (Nasdaq: AIFA) (“AIFA” or the “Company”) today provided a strategic update. Following the Company’s previously announced signing of agreements to acquire a controlling interest in HyalRoute Communication Group (“HyalRoute”) and advancement of the Hainan AIFA Silicon Photonics Supercomputing Center project, the Company is further accelerating project planning, policy coordination, financing arrangements, and cross-border resource integration around its dual-engine strategy of an “AI infrastructure network powered by optical technologies” and an “AI application services matrix.”
Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 CongressClinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients following a single target dose of CLN-978
InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public OfferingNew York, NY, June 05, 2026 (GLOBE NEWSWIRE) -- InterPrivate Investment Partners V, Inc. (the “Company”), a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, announced the closing of its initial public offering of 20,125,000 units, including 2,625,000 units issued pursuant to the exercise of the underwriters’ over-allotment option in full, at a price of $10.00 per unit on June 5, 2026. Total gross proceeds from the offering were $201.25 million before deducting underwriting discounts and commissions and other offering expenses payable by the Company.
LCID SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Lucid Group, Inc. Investors - Contact Kirby McInerney LLP by July 28, 2026NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Lucid Group, Inc. (“Lucid” or the “Company”) (
NASDAQ:LCID) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) SystemsDANBURY, Conn. and WESTLAKE VILLAGE, Calif., June 05, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions for cardiometabolic and orphan lung diseases, today announced new clinical and real‑world data related to Afrezza® (insulin human) Inhalation Powder and FUROSCIX® (furosemide injection) that will be presented at the American Diabetes Association’s (ADA) 2026 Scientific Sessions, taking place June 5-8, 2026, in New Orleans, Louisiana.
Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including as a complementary therapy alongside GLP-1 receptor agonists to enhance metabolic health outcomes • Clinical data presented at ADA from COVALENT-112 show improvements in HbA1c and C-peptide in type 1 diabetes patients treated with icovamenib, with no evidence of immune activation, and inflammatory markers stable or reduced • Additionally, the Company expanded its Phase I BMF-650 study to evaluate a rapid one-step titration and enhanced weight loss potential with its oral GLP-1 receptor agonist
Oban BioPharma Announces Presentation of Late-Breaking Abstract at ADA 2026 Highlighting OBT-676: A First-in-Class Small Molecule Combining Dual Amylin and Calcitonin Receptor Full Agonism (DACRA) with GLP-1, GIP and Glucagon (Triple-G) Receptor PartialSTAMFORD, Conn., June 05, 2026 (GLOBE NEWSWIRE) -- Oban BioPharma today announced that preclinical data for OBT-676, a lead small-molecule candidate for the treatment of obesity and type 2 diabetes, has been selected for a late-breaking presentation at the upcoming American Diabetes Association (ADA) 86th Scientific Sessions being held from June 5th-8th in New Orleans, LA. The study characterizes OBT-676 as a new molecular entity that achieves potent full agonism at the amylin and calcitonin receptors (DACRA) while simultaneously delivering partial agonism across the GLP-1, GIP, and glucagon (Triple-G) pathways. OBT-676 demonstrated significant reduction in food intake and adipose-selective weight loss in the industry-standard rat diet-induced obesity (DIO) model.
Yuno Provides Corporate Update as It Advances Toward Launch, Expands Leadership Team with Talent from Binance, and Positions for Global Prediction Market GrowthNEWARK, N.J., June 05, 2026 (GLOBE NEWSWIRE) -- Yuno, an emerging prediction markets platform focused on building global infrastructure for event-based trading and social participation, today provided a corporate update highlighting key milestones achieved ahead of launch, including leadership expansion, product development progress, international market strategy, and continued investment in regulatory infrastructure.
VRRM INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Verra Mobility CorporationNEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Verra Mobility Corporation (“Verra Mobility” or the “Company”) (
NASDAQ:VRRM) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.
GRAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Deadline on August 4, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Grail To Contact Him Directly To Discuss Their Options
Vireo Growth Inc. Completes Acquisition of Bridgewell Agribusiness LLC and Plans to Acquire Dispensaries in Nevada and MarylandMINNEAPOLIS, June 05, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), today announced the closing of its previously announced acquisition of all of the issued and outstanding partnership interests of Agribusiness Holdings Limited Partnership, including its subsidiary Bridgewell Agribusiness LLC (“Bridgewell”) among other subsidiaries, pursuant to a Securities Purchase Agreement entered into among the various sellers named therein (the “Sellers”) and certain other parties thereto (the “Bridgewell Transaction”).
Fairfax Files Early Warning Report in Respect of Blue Ant MediaTORONTO, June 05, 2026 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announced today that it has filed an early warning report (the “Early Warning Report”) under National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues in connection with its holdings of subordinate voting shares (“Subordinate Voting Shares”) of Blue Ant Media Corporation (TSX: BAMI) (“Blue Ant” or the “Corporation”).
TKROBOTS Launches AI Quant Trading Platform With Free Trial Access for New UsersTKROBOTS introduces an AI-powered crypto quantitative trading platform with automated execution, wallet management, daily settlement records, and free trial access for new users.
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)BEDFORD, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (
NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on June 1, 2026, Anika granted restricted stock units (“RSUs”) covering an aggregate of 3,360 shares of common stock to one newly hired non-executive employee. The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with Nasdaq Listing Rule 5635(c)(4), was made as a material inducement to the grantee’s acceptance of employment with Anika as a component of the grantee’s employment compensation.
dLocal to Report Second Quarter 2026 Financial ResultsMONTEVIDEO, Uruguay, June 05, 2026 (GLOBE NEWSWIRE) -- DLocal Limited (NASDAQ: DLO, “dLocal” or the “Company”), the leading cross-border payment platform connecting global merchants to emerging markets, intends to release financial results for its second fiscal quarter ended June 30, 2026 on August 13, 2026 after market close.
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June 05, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on June 1, 2026 (the “Grant Date”), ORIC granted a total of 34,800 non-qualified stock options and 5,900 restricted stock units to two new non-executive employees who began their employment with ORIC in May 2026.
Banner Health appoints Dr. John Rares Almasan as senior vice president, chief AI, data and infrastructure officerVeteran technology leader will drive AI strategy and infrastructure modernization of Banner’s integrated delivery system
Artisan Partners Asset Management Inc. Reports May 2026 Assets Under ManagementMILWAUKEE, June 05, 2026 (GLOBE NEWSWIRE) -- Artisan Partners Asset Management Inc. (
NYSE: APAM) today reported that its preliminary assets under management ("AUM") as of May 31, 2026 totaled $186.0 billion. Artisan Funds and Artisan Global Funds accounted for $92.3 billion of total firm AUM, while separate accounts and other AUM1 accounted for $93.7 billion. During the period, Artisan was notified that a U.S. sub-advisory mandate representing approximately $5.7 billion of assets in the U.S. Value Team’s Value Equity strategy is expected to terminate in early June 2026. The reduction in assets under management will have a muted impact on revenues given the nature of the mandate and its associated fees.
Voting Rights and Shares Capital of the CompanyIn accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)
Uniti Group Inc. Announces Pricing of $1.1 Billion Kinetic Fiber Securitization Notes OfferingLITTLE ROCK, Ark., June 05, 2026 (GLOBE NEWSWIRE) -- Uniti Group Inc. (the “Company,” “Uniti,” or “we”) (Nasdaq: UNIT) today announced that Kinetic ABS Issuer LLC, a limited-purpose, bankruptcy remote subsidiary of Uniti (the “Issuer”), has priced its offering of $1,140,710,000 aggregate principal amount of secured fiber network revenue term notes, consisting of $805,210,000 5.834% Series 2026-2, Class A-2 term notes, $134,200,000 6.224% Series 2026-2, Class B term notes and $201,300,000 7.536% Series 2026-2, Class C term notes, each with an anticipated repayment date in June 2033 (collectively, the “Notes”). Collectively, the Notes have a weighted average coupon rate of approximately 6.180%. The Notes are expected to be secured by certain residential fiber network assets and related customer agreements in the States of Texas, Arkansas, Kentucky, Ohio, Georgia, Iowa, Alabama, Florida, North Carolina and Oklahoma. Each of the Issuer and its direct parent entity and subsidiaries are designated as “unrestricted subsidiaries” under Uniti’s credit agreement and the indentures governing its outstanding senior notes. The offering is expected to close on July 15, 2026.
HRC Technology Solutions LLC Expands Scope and Is Successfully Reappraised at CMMI® Services Maturity Level 3, Reinforcing Its AI-Driven Operating ModelSOUTHLAKE, Texas, June 05, 2026 (GLOBE NEWSWIRE) -- HRC Technology Solutions LLC, a leading technology-enabled Revenue Cycle Management (RCM) solutions provider to U.S. healthcare organizations, today announced that its Revenue Cycle Management operations, HRC Labs, and Kollect1 (K1) have been successfully reappraised — and the appraisal scope expanded — at Maturity Level 3 of ISACA’s Capability Maturity Model Integration (CMMI®) Services model. The appraisal was performed by Univate Solutions.
Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for ObesityPublication presented concurrently with oral presentation at American Diabetes Association’s 86th Scientific Sessions from ACCESS development program with aleniglipron, a once-daily oral small molecule GLP-1 receptor agonist
Liftoff Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesREDWOOD CITY, Calif., June 05, 2026 (GLOBE NEWSWIRE) -- Liftoff Mobile, Inc. (“Liftoff”) (Nasdaq: LFTO), a global leader in performance marketing and monetization solutions for the app economy, announced today that it has closed its initial public offering of 21,850,000 shares of its common stock at a public offering price of $23.00 per share, including the full exercise by the underwriters of their option to purchase up to an additional 2,850,000 shares of common stock.
Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8AUSTIN, Texas and DURHAM, N.C., June 05, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (
NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3-blocking antibodies for the treatment of patients with inflammatory and immune-mediated diseases, today announced that it will host an investor call and webcast on Monday, June 8, 2026 at 8:00 a.m. ET to present comprehensive Phase 1 clinical data for SL-325, including safety, tolerability, pharmacokinetics, receptor occupancy, pharmacodynamic and immunogenicity results and provide a pipeline update.
U.S. Global Investors Announces Restatement of EPS for Q3 2026; Reported Financial Strength Remains UnchangedSAN ANTONIO, June 05, 2026 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (
NASDAQ: GROW) (the "Company"), a registered investment advisory firm1 with longstanding experience in global markets and specialized sectors, today announced that it has completed the restatement of its previously issued earnings per share (EPS) figures for the three-month and nine-month periods ended March 31, 2026, and has filed an amended Quarterly Report for the third quarter of fiscal year 2026 on Form 10-Q/A.
Exponent to Participate in a Fireside Chat at the Wells Fargo 16th Annual Industrials & Materials ConferenceMENLO PARK, Calif., June 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that Chief Executive Officer Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and Chief Financial Officer Eric Anderson will participate in a fireside chat at the following investor conference:
Linkage Global Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price RequirementTOKYO and NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- Linkage Global Inc. (
NASDAQ: UZX) (“Linkage Global” or the “Company”), a public company that engages in providing cross-border e-commerce integrated services, today announced that it has received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on June 3, 2026, notifying the Company that based on the closing bid price of the Class A ordinary shares of the Company for the last 30 consecutive business days, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share.
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)BRISBANE, Calif., June 05, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on June 2, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 28,800 shares of Class A common stock and restricted stock units (RSUs) underlying 14,150 shares of Class A common stock to ten (10) new employees under the Vera Therapeutics, Inc. 2024 Inducement Plan (Inducement Plan). The Compensation Committee approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).
Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesSAN FRANCISCO and VANCOUVER, British Columbia, June 05, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced that it has closed its previously announced public offering of 11,500,000 shares of its common stock, including 1,500,000 shares sold pursuant to the underwriters’ full exercise of their option to purchase additional shares. The shares of common stock were sold to the public at a price of $15.00 per share. The gross proceeds to Jade from the offering, before deducting the underwriting discounts and commissions and other offering expenses, were $172.5 million. All of the shares of common stock sold in the public offering were sold by Jade.
Rivus Pharmaceuticals Announces Preclinical Data for RV-8451, a Muscle-Preserving, Oral GLP-1, at ADA 2026 Scientific Sessions- Preclinical NHP data demonstrate significant fat‑specific weight loss with RV‑8451, while preserving lean mass and showing no gastrointestinal adverse events -
Lithium Ionic Files Annual and Interim Financial StatementsTORONTO, June 05, 2026 (GLOBE NEWSWIRE) -- Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the “Company”), is pleased to announce that it has filed its audited financial statements for the year ended December 31, 2025, accompanying management’s discussion and analysis and related Form 52-109FV1 CEO and CFO certifications of annual filings on under its SEDAR+ profile at www.sedarplus.com and on its website, www.lithiumionic.com. The Company has also filed its interim financial statements, accompanying management’s discussion and analysis and related officer certifications for the three months ended March 31, 2026.
POET TECHNOLOGIES CLASS ACTION ALERT: POET Technologies, Inc. Investors Have Until June 29th to Contact Bragar Eagel & Squire, P.C. To Seek Lead Plaintiff RoleBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In POET To Contact Him Directly To Discuss Their Options
Nominations Open for Organic Grower Summit's 2026 Grower of the Year AwardBuilding on last year's success, the John Deere-sponsored award returns with its celebrated four-finalist format
EquipmentShare to Present at the Wells Fargo 16th Annual Industrials & Materials ConferenceCOLUMBIA, Mo., June 05, 2026 (GLOBE NEWSWIRE) -- EquipmentShare.com Inc (
NASDAQ: EQPT) (“EquipmentShare”), a leader in connected jobsite technology and one of the largest construction equipment rental providers in the United States, today announced that it will participate in Wells Fargo’s 16th Annual Industrials & Materials Conference on Tuesday, June 9th, 2026. The conference will include a fireside chat by Mark Wopata, Chief Data Officer and EVP, Finance of EquipmentShare.
CN to Support BHP’s Jansen Potash Mine with Rail Service Connecting Saskatchewan Production to Global MarketsMONTREAL, June 05, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (
NYSE: CNI) has entered into a transportation agreement with BHP to support the movement of potash from the Jansen Potash Mine in Saskatchewan to export terminals on Canada’s West Coast, helping connect one of the world’s largest new potash developments to global markets.
Long Table Growth Corp. Announces Closing of $172.5 Million Initial Public Offering Including Exercise of Underwriters’ Over-Allotment Option in FullDALLAS, TX, June 05, 2026 (GLOBE NEWSWIRE) -- Long Table Growth Corp. (Nasdaq: LTGRU) (the “Company”) today announced the closing of its initial public offering of 17,250,000 units, which includes 2,250,000 units issued pursuant to the exercise by the underwriter of its over-allotment option in full, at a public offering price of $10.00 per unit. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share.
Centurion Acquisition Corp. Announces Postponement of Shareholders’ Meeting to Friday, June 12, 2026, and Extension of Redemption Request DeadlineNEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- Centurion Acquisition Corp., a Cayman Islands exempted company, (“Centurion” or the “Company”) (Nasdaq: ALF) today announced that it intends to postpone its previously announced Extraordinary General Meeting of shareholders (the “Meeting”) from June 9, 2026, at 11:00 a.m. Eastern Time, to June 12, 2026 at 11:00 a.m. Eastern Time to allow Centurion additional time to engage with shareholders.
WIX.COM INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Wix.com Ltd. on Behalf of Wix.com Stockholders and Encourages Investors to Contact the FirmNEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Wix.com (WIX) To Contact Him Directly To Discuss Their Options
How Can Beginners Use AI Stock Trading Bots? BulkQuant Launches a Stock Quant Trading Tool With Simple SetupBulkQuant introduces a simplified stock quant trading tool designed to help beginners explore AI stock trading bots without coding, complex setup, or advanced strategy configuration.
Palmetto Publishing Releases New Memoir Boys Cry Too by John Mark Clubb with Jacqueline RobothamA retired Navy Commander and Marine breaks decades of silence about childhood sexual abuse in a raw memoir newly published by Palmetto Publishing.
Alterra IOS Secures $244M Financing to Fuel Growth of National Industrial Outdoor Storage PlatformNational IOS leader secures loan from Blackstone Real Estate Debt Strategies to support rapidly growing industrial outdoor storage platform
Grupo Bimbo Surpasses 500,000 Hectares Under Regenerative Agriculture PracticesMEXICO CITY, June 05, 2026 (GLOBE NEWSWIRE) -- In the context of World Environment Day, Grupo Bimbo, the largest baking company in the world, reported that by the end of 2025 it has more than 500,000 hectares under regenerative agriculture practices, representing an increase of nearly 73% compared to the more than 290,000 hectares reported at the end of 2024. This progress strengthens the company’s work at the origin of its value chain and reflects its belief that its purpose of nourishing a better world begins with soil health.
Bragar Eagel & Squire, P.C. is Investigating Intuit Inc. on Behalf of Intuit Stockholders and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Intuit (INTU) To Contact Him Directly To Discuss Their Options
FS KKR CAPITAL ALERT: Bragar Eagel & Squire, P.C. Reminds FS KKR Capital Corp. Investors They Have Until July 6th to Seek Lead Plaintiff Role With The FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In FS KKR Capital (FSK) To Contact Him Directly To Discuss Their Options
Wedbush Securities Launches Full Support for CME Group’s 24/7 Cryptocurrency Futures TradingFirm Extends Around-the-Clock Market Access Through Advanced Technology, Operational Expertise, and Commitment to Capital Markets Innovation
STELLANTIS DEADLINE MONDAY JUNE 8th: Stellantis N.V. (NYSE:STLA) Investors Have Until June 8th to Seek Lead Plaintiff Role with Bragar Eagel & Squire, P.C.Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Stellantis (STLA) To Contact Him Directly To Discuss Their Options
Teva Presents New Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets that Show Patient- and Caregiver-Reported Improvements in Huntington's Disease ChoreaPARSIPPANY, N.J. and TEL AVIV, Israel, June 05, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new data from the first and only real-world, decentralized study evaluating the patient- and caregiver-reported quality of life impacts of Huntington’s disease (HD) chorea3 and the effect of AUSTEDO® or AUSTEDO XR® on symptom management. The findings demonstrate that treating chorea with AUSTEDO or AUSTEDO XR led to symptom improvement and, as a result, showed improvements across multiple quality of life measures.1,2 The data were presented at the Advanced Therapeutics in Movement & Related Disorders® Congress, held June 4 – 8, 2026, in Washington, DC.
WeTrade and Houston Rockets Lift Off with Multi-Year Global PartnershipThe collaboration connects millions of fans to the worlds of elite sport and global trading through fan engagement, international activations, and exclusive experiences
13th Monaco Energy Boat Challenge 8-11 July 2026 Monaco as a global laboratory for sustainable yachtingWith a record 56 teams signed up, innovation, energy and the future of navigation are set to converge on the 2026 Monaco Energy Boat Challenge
HELE Investors Have Opportunity to Lead Helen of Troy Limited Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, June 05, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Helen of Troy Limited (“Helen of Troy” or “the Company”) (
NASDAQ: HELE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
BMI Investors Have Opportunity to Lead Badger Meter, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, June 05, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Badger Meter, Inc. (“Badger” or “the Company”) (
NYSE: BMI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
EAA AIRVENTURE OSHKOSH SET FOR JULY 20-26“2026 Best Airshow” to celebrate the freedom of flight as part of America’s 250th annviersary
LCID Investors Have Opportunity to Lead Lucid Group, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, June 05, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lucid Group, Inc. (“Lucid” or “the Company”) (
NASDAQ: LCID) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
